| __timestamp | Gilead Sciences, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21102000000 | 125519000 |
| Thursday, January 1, 2015 | 28633000000 | 135522000 |
| Friday, January 1, 2016 | 26129000000 | 137780000 |
| Sunday, January 1, 2017 | 21736000000 | 162135000 |
| Monday, January 1, 2018 | 17274000000 | 174885000 |
| Tuesday, January 1, 2019 | 17774000000 | 174811000 |
| Wednesday, January 1, 2020 | 20117000000 | 138761000 |
| Friday, January 1, 2021 | 20704000000 | 187695000 |
| Saturday, January 1, 2022 | 21624000000 | 581703000 |
| Sunday, January 1, 2023 | 20618000000 | 709543000 |
| Monday, January 1, 2024 | 78200000 |
Igniting the spark of knowledge
In the ever-evolving landscape of the pharmaceutical industry, Gilead Sciences, Inc. and Lantheus Holdings, Inc. present a fascinating study in contrasts. Over the past decade, Gilead Sciences has consistently demonstrated robust financial health, with its gross profit peaking in 2015 at approximately 33% above its 2014 levels. However, the subsequent years saw a decline, with a notable dip in 2018, before stabilizing around 2020.
Conversely, Lantheus Holdings, while operating on a smaller scale, has shown remarkable growth. From 2014 to 2023, its gross profit surged by over 460%, highlighting its dynamic expansion strategy. The year 2022 marked a significant leap, with profits more than tripling compared to the previous year.
This comparison underscores the diverse strategies and market positions of these two industry players, offering valuable insights into their financial trajectories.
Gross Profit Trends Compared: Johnson & Johnson vs Gilead Sciences, Inc.
Gross Profit Analysis: Comparing Gilead Sciences, Inc. and Vertex Pharmaceuticals Incorporated
Gilead Sciences, Inc. and Zoetis Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Gilead Sciences, Inc. and Incyte Corporation Trends
Gilead Sciences, Inc. vs Lantheus Holdings, Inc.: Annual Revenue Growth Compared
Gross Profit Comparison: Gilead Sciences, Inc. and Exelixis, Inc. Trends
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Lantheus Holdings, Inc.
Gross Profit Analysis: Comparing Gilead Sciences, Inc. and Corcept Therapeutics Incorporated
Gross Profit Trends Compared: Gilead Sciences, Inc. vs Perrigo Company plc
Gilead Sciences, Inc. and Bausch Health Companies Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Vertex Pharmaceuticals Incorporated or Lantheus Holdings, Inc.
Key Insights on Gross Profit: Lantheus Holdings, Inc. vs Amneal Pharmaceuticals, Inc.